Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by symbiont of host defense response (GO:0052031) | 6.19641813 |
2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.19641813 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.19641813 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.19641813 |
5 | modulation by symbiont of host immune response (GO:0052553) | 6.19641813 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.19641813 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.83107089 |
8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.69153415 |
9 | macrophage activation involved in immune response (GO:0002281) | 5.28495232 |
10 | neutrophil activation involved in immune response (GO:0002283) | 5.07114533 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.81120175 |
12 | immunoglobulin mediated immune response (GO:0016064) | 4.79490518 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78143122 |
14 | detection of other organism (GO:0098543) | 4.71146891 |
15 | regulation of interferon-alpha production (GO:0032647) | 4.56409422 |
16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.43631509 |
17 | response to peptidoglycan (GO:0032494) | 4.43362270 |
18 | microglial cell activation (GO:0001774) | 4.40900344 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40526840 |
20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40526840 |
21 | respiratory burst (GO:0045730) | 4.39024161 |
22 | detection of bacterium (GO:0016045) | 4.36121333 |
23 | positive regulation of B cell differentiation (GO:0045579) | 4.28603449 |
24 | detection of external biotic stimulus (GO:0098581) | 4.26379901 |
25 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.23630630 |
26 | response to host immune response (GO:0052572) | 4.22910835 |
27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.22910835 |
28 | neutrophil activation (GO:0042119) | 4.03569543 |
29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95795490 |
30 | response to host (GO:0075136) | 3.95795490 |
31 | response to host defenses (GO:0052200) | 3.95795490 |
32 | * B cell receptor signaling pathway (GO:0050853) | 3.94225955 |
33 | granulocyte activation (GO:0036230) | 3.89504055 |
34 | regulation of B cell differentiation (GO:0045577) | 3.85619149 |
35 | macrophage activation (GO:0042116) | 3.81536009 |
36 | detection of biotic stimulus (GO:0009595) | 3.78445276 |
37 | cellular extravasation (GO:0045123) | 3.76151833 |
38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.74540406 |
39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.74507583 |
40 | myeloid cell activation involved in immune response (GO:0002275) | 3.73749063 |
41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66774609 |
42 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.66338019 |
43 | B cell mediated immunity (GO:0019724) | 3.55199500 |
44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.53669132 |
45 | positive regulation of mast cell degranulation (GO:0043306) | 3.53669132 |
46 | positive regulation of mast cell activation (GO:0033005) | 3.50841199 |
47 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50425650 |
48 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.48201368 |
49 | response to muramyl dipeptide (GO:0032495) | 3.45608670 |
50 | positive regulation of interferon-beta production (GO:0032728) | 3.45525335 |
51 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43417047 |
52 | defense response to protozoan (GO:0042832) | 3.42059416 |
53 | cellular response to zinc ion (GO:0071294) | 3.39980508 |
54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38526114 |
55 | T-helper 1 type immune response (GO:0042088) | 3.33643016 |
56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33520719 |
57 | response to type I interferon (GO:0034340) | 3.31938134 |
58 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.30954734 |
59 | type I interferon signaling pathway (GO:0060337) | 3.29494561 |
60 | cellular response to type I interferon (GO:0071357) | 3.29494561 |
61 | leukocyte aggregation (GO:0070486) | 3.28374681 |
62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.27165523 |
63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.25969637 |
64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25246948 |
65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23737415 |
66 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.23444791 |
67 | germinal center formation (GO:0002467) | 3.22403533 |
68 | response to interleukin-15 (GO:0070672) | 3.22216178 |
69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.19565643 |
70 | regulation of antigen processing and presentation (GO:0002577) | 3.17931264 |
71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17548714 |
72 | I-kappaB phosphorylation (GO:0007252) | 3.16562553 |
73 | regulation of tolerance induction (GO:0002643) | 3.16514828 |
74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.14460788 |
75 | T cell migration (GO:0072678) | 3.11168597 |
76 | response to protozoan (GO:0001562) | 3.11022102 |
77 | mature B cell differentiation (GO:0002335) | 3.10874118 |
78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07892895 |
79 | negative regulation of granulocyte differentiation (GO:0030853) | 3.07886302 |
80 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.07689307 |
81 | regulation of T cell tolerance induction (GO:0002664) | 3.05380310 |
82 | positive regulation of type 2 immune response (GO:0002830) | 3.05097907 |
83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04809662 |
84 | myeloid leukocyte activation (GO:0002274) | 3.04805822 |
85 | pinocytosis (GO:0006907) | 3.04629356 |
86 | * regulation of mast cell degranulation (GO:0043304) | 3.04225869 |
87 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03841266 |
88 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03087556 |
89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02247011 |
90 | * regulation of mast cell activation (GO:0033003) | 3.00045863 |
91 | regulation of gamma-delta T cell activation (GO:0046643) | 2.99257132 |
92 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98350984 |
93 | neutrophil mediated immunity (GO:0002446) | 2.97403263 |
94 | negative regulation of phagocytosis (GO:0050765) | 2.96936458 |
95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.96797593 |
96 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95444905 |
97 | myeloid dendritic cell activation (GO:0001773) | 2.94064430 |
98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93115705 |
99 | cellular response to exogenous dsRNA (GO:0071360) | 2.92948924 |
100 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.92884636 |
101 | natural killer cell mediated immunity (GO:0002228) | 2.92884636 |
102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92614532 |
103 | negative regulation of interleukin-12 production (GO:0032695) | 2.91726749 |
104 | leukocyte degranulation (GO:0043299) | 2.91401616 |
105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90560765 |
106 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89519472 |
107 | cellular response to interleukin-15 (GO:0071350) | 2.88077147 |
108 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.87644625 |
109 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86878774 |
110 | myeloid dendritic cell differentiation (GO:0043011) | 2.84826355 |
111 | leukocyte mediated cytotoxicity (GO:0001909) | 2.84346141 |
112 | * regulation of mast cell activation involved in immune response (GO:0033006) | 2.83333031 |
113 | negative thymic T cell selection (GO:0045060) | 2.82812507 |
114 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82246581 |
115 | regulation of interleukin-12 production (GO:0032655) | 2.82067655 |
116 | negative regulation of mast cell activation (GO:0033004) | 2.81800561 |
117 | negative regulation of cell killing (GO:0031342) | 2.80088535 |
118 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80088535 |
119 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77258693 |
120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75313491 |
121 | superoxide anion generation (GO:0042554) | 2.73895052 |
122 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.72685643 |
123 | regulation of interferon-beta production (GO:0032648) | 2.70228487 |
124 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.69619467 |
125 | neutrophil chemotaxis (GO:0030593) | 2.69144402 |
126 | leukocyte cell-cell adhesion (GO:0007159) | 2.68672596 |
127 | NIK/NF-kappaB signaling (GO:0038061) | 2.68128081 |
128 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.67949973 |
129 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67566070 |
130 | cellular response to interferon-beta (GO:0035458) | 2.66454712 |
131 | detection of molecule of bacterial origin (GO:0032490) | 2.66126433 |
132 | negative regulation of interleukin-6 production (GO:0032715) | 2.64280335 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.33268914 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.76596906 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.51539821 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.15572246 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.87987582 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.86057500 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65529923 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.62564159 |
9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43917958 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.29625583 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.23542419 |
12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.10814426 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08188324 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.07025871 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.69591063 |
16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.63438989 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57260454 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51968598 |
19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.43437793 |
20 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39972814 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.38029294 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30833969 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27035037 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23944772 |
25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20148279 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13317665 |
27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12363920 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 2.09452854 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06604165 |
30 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.02500735 |
31 | MAF_26560356_Chip-Seq_TH1_Human | 2.00854227 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 1.99835476 |
33 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.95412632 |
34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93418482 |
35 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92968512 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92107886 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90895471 |
38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87124002 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.84340479 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83327002 |
41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77884154 |
42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.71147788 |
43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69220557 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68005696 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58331097 |
46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57806011 |
47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56700274 |
48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55930277 |
49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46617952 |
50 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45524499 |
51 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43875708 |
52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39713699 |
53 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36741516 |
54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36679688 |
55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32851921 |
56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31180857 |
57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29953349 |
58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24334141 |
59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23600945 |
60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22936487 |
61 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22334817 |
62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21056972 |
63 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21030121 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21003243 |
65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20666848 |
66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17447833 |
67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13349382 |
68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13148950 |
69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12622395 |
70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11455644 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10556177 |
72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10422619 |
73 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10417343 |
74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09438228 |
75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06046828 |
76 | MAF_26560356_Chip-Seq_TH2_Human | 1.05420074 |
77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05385328 |
78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04361635 |
79 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00569145 |
80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00263923 |
81 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99644493 |
82 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99208183 |
83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98414841 |
84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97322290 |
85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94405018 |
86 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94272611 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93936243 |
88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93606148 |
89 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93275426 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92357342 |
91 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91748982 |
92 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.91448796 |
93 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90338933 |
94 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87325207 |
95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86669407 |
96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85395542 |
97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.82666846 |
98 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82004203 |
99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81667174 |
100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81360327 |
101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80952832 |
102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80951171 |
103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80865945 |
104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80738476 |
105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80695336 |
106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78596230 |
107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74672589 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72793057 |
109 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72137246 |
110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.71818695 |
111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71525858 |
112 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71215186 |
113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70912246 |
114 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.69709685 |
115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68879119 |
116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65799633 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 4.41727319 |
2 | MP0003436_decreased_susceptibility_to | 3.41713374 |
3 | MP0001790_abnormal_immune_system | 2.99925515 |
4 | MP0005387_immune_system_phenotype | 2.99925515 |
5 | MP0009785_altered_susceptibility_to | 2.99159264 |
6 | * MP0001800_abnormal_humoral_immune | 2.99159263 |
7 | * MP0002419_abnormal_innate_immunity | 2.97866154 |
8 | * MP0005000_abnormal_immune_tolerance | 2.90203717 |
9 | * MP0002452_abnormal_antigen_presenting | 2.86748252 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.84053639 |
11 | MP0000685_abnormal_immune_system | 2.75269047 |
12 | MP0005025_abnormal_response_to | 2.70632981 |
13 | MP0005671_abnormal_response_to | 2.67952165 |
14 | * MP0002723_abnormal_immune_serum | 2.55149739 |
15 | MP0006082_CNS_inflammation | 2.53411103 |
16 | * MP0003303_peritoneal_inflammation | 2.50769082 |
17 | MP0005058_abnormal_lysosome_morphology | 2.49804355 |
18 | MP0003724_increased_susceptibility_to | 2.43631969 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.42150732 |
20 | MP0005464_abnormal_platelet_physiology | 2.40707724 |
21 | * MP0002420_abnormal_adaptive_immunity | 2.39278725 |
22 | * MP0001819_abnormal_immune_cell | 2.39145337 |
23 | MP0004510_myositis | 2.16828181 |
24 | MP0001853_heart_inflammation | 2.02989908 |
25 | MP0003300_gastrointestinal_ulcer | 2.01135880 |
26 | MP0008260_abnormal_autophagy | 2.01051819 |
27 | MP0002405_respiratory_system_inflammati | 1.92706933 |
28 | MP0009278_abnormal_bone_marrow | 1.91315783 |
29 | MP0005451_abnormal_body_composition | 1.91000773 |
30 | * MP0002398_abnormal_bone_marrow | 1.87993642 |
31 | * MP0000716_abnormal_immune_system | 1.87960539 |
32 | MP0001533_abnormal_skeleton_physiology | 1.86694443 |
33 | * MP0001845_abnormal_inflammatory_respons | 1.85371891 |
34 | MP0002166_altered_tumor_susceptibility | 1.82060204 |
35 | MP0003172_abnormal_lysosome_physiology | 1.81695963 |
36 | * MP0000689_abnormal_spleen_morphology | 1.71920916 |
37 | MP0002396_abnormal_hematopoietic_system | 1.68769801 |
38 | MP0010155_abnormal_intestine_physiology | 1.68343280 |
39 | MP0004947_skin_inflammation | 1.67080688 |
40 | MP0009840_abnormal_foam_cell | 1.64670276 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.64101980 |
42 | MP0001545_abnormal_hematopoietic_system | 1.64101980 |
43 | MP0002006_tumorigenesis | 1.60714866 |
44 | MP0000343_altered_response_to | 1.60497293 |
45 | * MP0008469_abnormal_protein_level | 1.58895673 |
46 | * MP0002429_abnormal_blood_cell | 1.57343900 |
47 | MP0003183_abnormal_peptide_metabolism | 1.55331363 |
48 | * MP0002722_abnormal_immune_system | 1.50644984 |
49 | MP0009764_decreased_sensitivity_to | 1.49503138 |
50 | MP0000465_gastrointestinal_hemorrhage | 1.49442514 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.46655860 |
52 | MP0003075_altered_response_to | 1.43338045 |
53 | MP0004808_abnormal_hematopoietic_stem | 1.42287546 |
54 | MP0002132_abnormal_respiratory_system | 1.38048657 |
55 | MP0001873_stomach_inflammation | 1.34343412 |
56 | MP0003448_altered_tumor_morphology | 1.32317116 |
57 | MP0005310_abnormal_salivary_gland | 1.28061560 |
58 | MP0008004_abnormal_stomach_pH | 1.21932695 |
59 | MP0005167_abnormal_blood-brain_barrier | 1.18237083 |
60 | MP0003828_pulmonary_edema | 1.15356194 |
61 | MP0005166_decreased_susceptibility_to | 1.14965980 |
62 | MP0002138_abnormal_hepatobiliary_system | 1.10913066 |
63 | MP0002998_abnormal_bone_remodeling | 1.10798356 |
64 | MP0000569_abnormal_digit_pigmentation | 1.08726831 |
65 | MP0003566_abnormal_cell_adhesion | 1.08248431 |
66 | MP0002277_abnormal_respiratory_mucosa | 1.08091262 |
67 | MP0002933_joint_inflammation | 1.08057645 |
68 | MP0000858_altered_metastatic_potential | 1.08017768 |
69 | MP0001851_eye_inflammation | 1.07552067 |
70 | MP0003763_abnormal_thymus_physiology | 1.05804947 |
71 | MP0005174_abnormal_tail_pigmentation | 1.03110443 |
72 | MP0006054_spinal_hemorrhage | 1.01039341 |
73 | MP0004381_abnormal_hair_follicle | 1.00466721 |
74 | MP0000249_abnormal_blood_vessel | 1.00434422 |
75 | MP0009763_increased_sensitivity_to | 0.99373053 |
76 | MP0010307_abnormal_tumor_latency | 0.97105547 |
77 | MP0001879_abnormal_lymphatic_vessel | 0.90117377 |
78 | MP0003806_abnormal_nucleotide_metabolis | 0.89261151 |
79 | MP0010352_gastrointestinal_tract_polyps | 0.88328241 |
80 | MP0000604_amyloidosis | 0.88107540 |
81 | MP0005164_abnormal_response_to | 0.87305464 |
82 | MP0000490_abnormal_crypts_of | 0.87278116 |
83 | MP0000767_abnormal_smooth_muscle | 0.86928630 |
84 | MP0000703_abnormal_thymus_morphology | 0.84667221 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 0.83544338 |
86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82637545 |
87 | MP0005076_abnormal_cell_differentiation | 0.81103322 |
88 | MP0003866_abnormal_defecation | 0.80634829 |
89 | MP0005390_skeleton_phenotype | 0.79801254 |
90 | MP0002332_abnormal_exercise_endurance | 0.79597078 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.79269746 |
92 | MP0002928_abnormal_bile_duct | 0.79075271 |
93 | MP0004782_abnormal_surfactant_physiolog | 0.78981851 |
94 | MP0003045_fibrosis | 0.77122072 |
95 | MP0005023_abnormal_wound_healing | 0.76644320 |
96 | MP0003279_aneurysm | 0.76218840 |
97 | MP0004883_abnormal_blood_vessel | 0.75917497 |
98 | * MP0002136_abnormal_kidney_physiology | 0.74552017 |
99 | MP0002254_reproductive_system_inflammat | 0.74222954 |
100 | * MP0003690_abnormal_glial_cell | 0.73877090 |
101 | * MP0000609_abnormal_liver_physiology | 0.72137527 |
102 | MP0005075_abnormal_melanosome_morpholog | 0.70981949 |
103 | MP0003453_abnormal_keratinocyte_physiol | 0.70166446 |
104 | MP0001915_intracranial_hemorrhage | 0.69932767 |
105 | MP0003091_abnormal_cell_migration | 0.69820481 |
106 | * MP0001663_abnormal_digestive_system | 0.67890623 |
107 | MP0002019_abnormal_tumor_incidence | 0.67305457 |
108 | MP0008874_decreased_physiological_sensi | 0.66600209 |
109 | MP0008873_increased_physiological_sensi | 0.65062672 |
110 | MP0000598_abnormal_liver_morphology | 0.64076147 |
111 | MP0000371_diluted_coat_color | 0.60729193 |
112 | MP0003186_abnormal_redox_activity | 0.60123840 |
113 | MP0003795_abnormal_bone_structure | 0.59631114 |
114 | MP0000015_abnormal_ear_pigmentation | 0.59320172 |
115 | MP0005319_abnormal_enzyme/_coenzyme | 0.53210373 |
116 | MP0002009_preneoplasia | 0.52981066 |
117 | MP0005376_homeostasis/metabolism_phenot | 0.48536990 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.72926135 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.26446659 |
3 | Eczematoid dermatitis (HP:0000976) | 5.94563184 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.16335435 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.63405199 |
6 | Cellulitis (HP:0100658) | 4.31119339 |
7 | Abnormality of macrophages (HP:0004311) | 4.13413566 |
8 | Recurrent skin infections (HP:0001581) | 4.08643708 |
9 | Gastrointestinal infarctions (HP:0005244) | 4.01220202 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.97523469 |
11 | Recurrent fungal infections (HP:0002841) | 3.88486113 |
12 | Colitis (HP:0002583) | 3.87134335 |
13 | Myositis (HP:0100614) | 3.86350159 |
14 | Recurrent viral infections (HP:0004429) | 3.82655351 |
15 | Keratoconjunctivitis sicca (HP:0001097) | 3.78457741 |
16 | Encephalitis (HP:0002383) | 3.62440290 |
17 | Glomerulonephritis (HP:0000099) | 3.60264370 |
18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.60110372 |
19 | Agammaglobulinemia (HP:0004432) | 3.57274021 |
20 | Increased cerebral lipofuscin (HP:0011813) | 3.54431185 |
21 | Keratoconjunctivitis (HP:0001096) | 3.51042194 |
22 | Vacuolated lymphocytes (HP:0001922) | 3.50848160 |
23 | Autoimmune thrombocytopenia (HP:0001973) | 3.45812333 |
24 | Hematochezia (HP:0002573) | 3.43476091 |
25 | Vasculitis (HP:0002633) | 3.39447120 |
26 | Obstructive lung disease (HP:0006536) | 3.38553003 |
27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38553003 |
28 | Meningitis (HP:0001287) | 3.37455394 |
29 | Inflammation of the large intestine (HP:0002037) | 3.37369628 |
30 | IgM deficiency (HP:0002850) | 3.27500219 |
31 | Gingivitis (HP:0000230) | 3.27198242 |
32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26871045 |
33 | Orchitis (HP:0100796) | 3.23290501 |
34 | Gastrointestinal inflammation (HP:0004386) | 3.19527017 |
35 | T lymphocytopenia (HP:0005403) | 3.19226914 |
36 | Spontaneous hematomas (HP:0007420) | 3.18090822 |
37 | Interstitial pulmonary disease (HP:0006530) | 3.17417352 |
38 | Osteomyelitis (HP:0002754) | 3.15915353 |
39 | Chest pain (HP:0100749) | 3.11169537 |
40 | Gastrointestinal stroma tumor (HP:0100723) | 3.11074861 |
41 | Abnormality of T cell number (HP:0011839) | 3.09569042 |
42 | Chronic otitis media (HP:0000389) | 3.08348667 |
43 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00464423 |
44 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00464423 |
45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99572489 |
46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99572489 |
47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99572489 |
48 | Pustule (HP:0200039) | 2.97822840 |
49 | Periodontitis (HP:0000704) | 2.95512290 |
50 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.80973620 |
51 | Recurrent bronchitis (HP:0002837) | 2.80376055 |
52 | Dysostosis multiplex (HP:0000943) | 2.80278417 |
53 | Recurrent pneumonia (HP:0006532) | 2.77569593 |
54 | Optic neuritis (HP:0100653) | 2.75153976 |
55 | Retrobulbar optic neuritis (HP:0100654) | 2.75153976 |
56 | Anorexia (HP:0002039) | 2.67554250 |
57 | Episodic fever (HP:0001954) | 2.64812473 |
58 | Abnormality of T cells (HP:0002843) | 2.64673713 |
59 | Increased IgM level (HP:0003496) | 2.63061518 |
60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61930792 |
61 | Myocardial infarction (HP:0001658) | 2.61652230 |
62 | Amyloidosis (HP:0011034) | 2.61024169 |
63 | Pulmonary embolism (HP:0002204) | 2.60406851 |
64 | Gangrene (HP:0100758) | 2.56560622 |
65 | Urticaria (HP:0001025) | 2.54453357 |
66 | Recurrent lower respiratory tract infections (HP:0002783) | 2.53614441 |
67 | Petechiae (HP:0000967) | 2.53367512 |
68 | Complement deficiency (HP:0004431) | 2.52358425 |
69 | Disinhibition (HP:0000734) | 2.50526097 |
70 | Stomatitis (HP:0010280) | 2.47323586 |
71 | Gingival bleeding (HP:0000225) | 2.46225137 |
72 | Pulmonary infiltrates (HP:0002113) | 2.45991683 |
73 | Lymphopenia (HP:0001888) | 2.45900295 |
74 | Arterial thrombosis (HP:0004420) | 2.43400716 |
75 | Prolonged bleeding time (HP:0003010) | 2.42761010 |
76 | Peritonitis (HP:0002586) | 2.42400030 |
77 | Basal ganglia calcification (HP:0002135) | 2.42004977 |
78 | Axonal loss (HP:0003447) | 2.41029740 |
79 | Granulocytopenia (HP:0001913) | 2.39562464 |
80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38421773 |
81 | Abnormality of complement system (HP:0005339) | 2.37247048 |
82 | Abnormality of the pleura (HP:0002103) | 2.35996168 |
83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35440908 |
84 | Mucopolysacchariduria (HP:0008155) | 2.35440908 |
85 | Nephritis (HP:0000123) | 2.34405334 |
86 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34235851 |
87 | Epistaxis (HP:0000421) | 2.31703080 |
88 | Thrombocytosis (HP:0001894) | 2.31351453 |
89 | Recurrent sinusitis (HP:0011108) | 2.31248296 |
90 | Papilloma (HP:0012740) | 2.30482545 |
91 | Verrucae (HP:0200043) | 2.30482545 |
92 | Leukocytosis (HP:0001974) | 2.30304622 |
93 | Abnormal platelet function (HP:0011869) | 2.28282142 |
94 | Impaired platelet aggregation (HP:0003540) | 2.28282142 |
95 | Emphysema (HP:0002097) | 2.27803372 |
96 | Hypochromic anemia (HP:0001931) | 2.23512232 |
97 | Increased serum ferritin (HP:0003281) | 2.22659264 |
98 | Abnormality of the peritoneum (HP:0002585) | 2.22334660 |
99 | Hypochromic microcytic anemia (HP:0004840) | 2.22173208 |
100 | Prostate neoplasm (HP:0100787) | 2.21892107 |
101 | Purpura (HP:0000979) | 2.21372487 |
102 | Sepsis (HP:0100806) | 2.21176065 |
103 | Joint hemorrhage (HP:0005261) | 2.20004502 |
104 | Viral hepatitis (HP:0006562) | 2.19476141 |
105 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18931877 |
106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18931877 |
107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18931877 |
108 | Skin ulcer (HP:0200042) | 2.18688954 |
109 | Abnormality of the nasal mucosa (HP:0000433) | 2.18248485 |
110 | Agnosia (HP:0010524) | 2.17902352 |
111 | Panhypogammaglobulinemia (HP:0003139) | 2.17508022 |
112 | Autoimmune hemolytic anemia (HP:0001890) | 2.17022524 |
113 | Thyroiditis (HP:0100646) | 2.16351212 |
114 | Hypergammaglobulinemia (HP:0010702) | 2.15366705 |
115 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15267662 |
116 | Osteolytic defects of the hand bones (HP:0009699) | 2.15267662 |
117 | Restrictive lung disease (HP:0002091) | 2.14561009 |
118 | Vertigo (HP:0002321) | 2.14148785 |
119 | Abnormality of T cell physiology (HP:0011840) | 2.13539016 |
120 | Amaurosis fugax (HP:0100576) | 2.13185509 |
121 | Chronic diarrhea (HP:0002028) | 2.12543581 |
122 | Slow saccadic eye movements (HP:0000514) | 2.11959517 |
123 | Increased IgE level (HP:0003212) | 2.10675601 |
124 | Loss of speech (HP:0002371) | 2.10356619 |
125 | Eosinophilia (HP:0001880) | 2.10063562 |
126 | Glomerulopathy (HP:0100820) | 2.08998964 |
127 | Abnormality of the endocardium (HP:0004306) | 2.07645795 |
128 | Polyneuropathy (HP:0001271) | 2.06862415 |
129 | Hemoptysis (HP:0002105) | 2.05714034 |
130 | Hepatosplenomegaly (HP:0001433) | 2.05064432 |
131 | Nasal polyposis (HP:0100582) | 2.04189922 |
132 | Abnormality of iron homeostasis (HP:0011031) | 2.03961736 |
133 | IgA deficiency (HP:0002720) | 2.02739437 |
134 | Premature loss of primary teeth (HP:0006323) | 1.95929789 |
135 | Keratitis (HP:0000491) | 1.93879053 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.01826221 |
2 | BLK | 3.43570894 |
3 | ERN1 | 3.32706608 |
4 | TYK2 | 3.19744457 |
5 | RIPK4 | 3.19324985 |
6 | IRAK4 | 2.98669841 |
7 | TGFBR2 | 2.97992927 |
8 | MAP3K14 | 2.97863649 |
9 | TBK1 | 2.76513597 |
10 | KIT | 2.55001386 |
11 | PRPF4B | 2.50069962 |
12 | IRAK3 | 2.49343642 |
13 | CSF1R | 2.48791053 |
14 | JAK1 | 2.07689662 |
15 | STK10 | 1.99155550 |
16 | BTK | 1.92522189 |
17 | IKBKE | 1.82983360 |
18 | SYK | 1.78453660 |
19 | BMPR2 | 1.76079341 |
20 | IKBKB | 1.75606853 |
21 | JAK3 | 1.67954916 |
22 | MAP3K10 | 1.66213702 |
23 | ZAP70 | 1.61481558 |
24 | TNK2 | 1.57166392 |
25 | TAOK1 | 1.51497539 |
26 | MAP3K13 | 1.50743173 |
27 | HCK | 1.49383381 |
28 | NEK9 | 1.45862508 |
29 | TEC | 1.44306351 |
30 | GRK6 | 1.44070328 |
31 | TAOK3 | 1.43796766 |
32 | MAP2K3 | 1.43614366 |
33 | EPHB1 | 1.42079127 |
34 | FES | 1.38422840 |
35 | IRAK1 | 1.38418427 |
36 | LRRK2 | 1.31183881 |
37 | * LYN | 1.29597555 |
38 | MAP3K1 | 1.28960801 |
39 | CLK1 | 1.28067815 |
40 | PIM1 | 1.23912654 |
41 | TXK | 1.22541205 |
42 | RPS6KA4 | 1.21715305 |
43 | * CSK | 1.21695437 |
44 | IRAK2 | 1.18328632 |
45 | KSR2 | 1.11913570 |
46 | TAOK2 | 1.10596479 |
47 | LCK | 1.10274826 |
48 | CHUK | 1.10190459 |
49 | KDR | 1.07012091 |
50 | PIM2 | 1.06048822 |
51 | CAMK1D | 1.04230037 |
52 | STK4 | 1.01933878 |
53 | JAK2 | 0.99232950 |
54 | ITK | 0.96676827 |
55 | SIK2 | 0.96632617 |
56 | PKN2 | 0.95264532 |
57 | FGFR4 | 0.95034945 |
58 | FGR | 0.94958764 |
59 | FGFR3 | 0.92648800 |
60 | MARK3 | 0.91337941 |
61 | TRIB3 | 0.86613920 |
62 | GRK7 | 0.81488721 |
63 | CDC42BPA | 0.77775180 |
64 | PTK6 | 0.75783476 |
65 | MAP3K5 | 0.73995962 |
66 | MARK2 | 0.73282658 |
67 | TRPM7 | 0.71890342 |
68 | FLT3 | 0.69748063 |
69 | MAP3K6 | 0.69242188 |
70 | MAP3K2 | 0.67928736 |
71 | EEF2K | 0.67557816 |
72 | CDK19 | 0.66847741 |
73 | MAP3K3 | 0.64512828 |
74 | CDK6 | 0.64045961 |
75 | PAK4 | 0.62208189 |
76 | ABL1 | 0.61658612 |
77 | MST4 | 0.57193714 |
78 | EGFR | 0.56208431 |
79 | EPHA3 | 0.56140593 |
80 | PRKCD | 0.53677638 |
81 | RIPK1 | 0.53292334 |
82 | PTK2B | 0.51199176 |
83 | TTN | 0.49541466 |
84 | PRKD2 | 0.49349478 |
85 | SGK3 | 0.49232059 |
86 | STK3 | 0.49038051 |
87 | HIPK2 | 0.48962512 |
88 | MAPKAPK2 | 0.48936957 |
89 | CAMK1G | 0.47633032 |
90 | PDK1 | 0.46636744 |
91 | MAPK4 | 0.46574400 |
92 | CDK4 | 0.46172475 |
93 | MAPK12 | 0.46026396 |
94 | RAF1 | 0.45965694 |
95 | TESK2 | 0.45734879 |
96 | SMG1 | 0.45660805 |
97 | RPS6KA6 | 0.44065924 |
98 | TIE1 | 0.42332122 |
99 | PRKCQ | 0.41680047 |
100 | NLK | 0.40239156 |
101 | MAP3K8 | 0.39731400 |
102 | CDK12 | 0.39240633 |
103 | DAPK2 | 0.38012932 |
104 | CDK9 | 0.37572618 |
105 | NME2 | 0.36782833 |
106 | SGK2 | 0.36691829 |
107 | MAP3K7 | 0.35928461 |
108 | MOS | 0.35480672 |
109 | KSR1 | 0.35375527 |
110 | NEK2 | 0.35214511 |
111 | PIK3CG | 0.34842190 |
112 | TGFBR1 | 0.34539487 |
113 | ACVR1B | 0.34499453 |
114 | STK24 | 0.34301123 |
115 | DYRK1B | 0.34292838 |
116 | MAP2K4 | 0.34269786 |
117 | SCYL2 | 0.34053679 |
118 | STK11 | 0.34022430 |
119 | YES1 | 0.33770098 |
120 | MAP2K6 | 0.33492512 |
121 | MAPK15 | 0.33417873 |
122 | RPS6KL1 | 0.33391800 |
123 | RPS6KC1 | 0.33391800 |
124 | MAPK11 | 0.32501044 |
125 | EIF2AK2 | 0.31813182 |
126 | MAP3K11 | 0.31555412 |
127 | SIK3 | 0.31203232 |
128 | MAPK7 | 0.31093287 |
129 | DYRK3 | 0.30575788 |
130 | CAMKK2 | 0.30473093 |
131 | GRK1 | 0.30362185 |
132 | FYN | 0.29176185 |
133 | PRKCH | 0.28683263 |
134 | PBK | 0.28468666 |
135 | PDPK1 | 0.28417486 |
136 | PRKAA2 | 0.27858272 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.62275432 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.38721861 |
3 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.93572797 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.75736071 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.54984163 |
6 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41705982 |
7 | Pertussis_Homo sapiens_hsa05133 | 2.24435961 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17474494 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.14048437 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.12402106 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12208858 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.12048075 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01320888 |
14 | Measles_Homo sapiens_hsa05162 | 1.98077120 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97168942 |
16 | Malaria_Homo sapiens_hsa05144 | 1.94903214 |
17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92913104 |
18 | Lysosome_Homo sapiens_hsa04142 | 1.91351964 |
19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86665224 |
20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80492636 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78318636 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74819052 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.72146166 |
24 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69394094 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69377725 |
26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57316208 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56587163 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56504070 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48827388 |
30 | Shigellosis_Homo sapiens_hsa05131 | 1.39295613 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.38662455 |
32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38203537 |
33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37711994 |
34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37697755 |
35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36833190 |
36 | Salmonella infection_Homo sapiens_hsa05132 | 1.36567439 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34417889 |
38 | Allograft rejection_Homo sapiens_hsa05330 | 1.26199828 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25715553 |
40 | Phagosome_Homo sapiens_hsa04145 | 1.23764937 |
41 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22601995 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 1.22412982 |
43 | Asthma_Homo sapiens_hsa05310 | 1.16655216 |
44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16414297 |
45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12941714 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07918569 |
47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05464591 |
48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01921347 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01192987 |
50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00178452 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99940448 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.98122455 |
53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97941131 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97834107 |
55 | * Platelet activation_Homo sapiens_hsa04611 | 0.96805829 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86825316 |
57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85659573 |
58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84917688 |
59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82958824 |
60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82692692 |
61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68607065 |
62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68522250 |
63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68210596 |
64 | Amoebiasis_Homo sapiens_hsa05146 | 0.67093062 |
65 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66974824 |
66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66256349 |
67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64994928 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62317358 |
69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62236283 |
70 | ABC transporters_Homo sapiens_hsa02010 | 0.59787895 |
71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59089734 |
72 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58140169 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55823240 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49431532 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47233529 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45590079 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.44685430 |
78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44573239 |
79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44361053 |
80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44335002 |
81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44320966 |
82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44095206 |
83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43180092 |
84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42236545 |
85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42128938 |
86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41762648 |
87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41376796 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40558784 |
89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40306508 |
90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39868918 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39516847 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.39373789 |
93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39160088 |
94 | Prion diseases_Homo sapiens_hsa05020 | 0.37556963 |
95 | Bladder cancer_Homo sapiens_hsa05219 | 0.37484632 |
96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37299411 |
97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37233457 |
98 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36561182 |
99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35102682 |
100 | Prostate cancer_Homo sapiens_hsa05215 | 0.34353303 |
101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33974133 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33606156 |
103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32201648 |
104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31816230 |
105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31552462 |
106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31004185 |
107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29996393 |
108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29459119 |
109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27921099 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26998138 |
111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26672807 |
112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25547726 |
113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24987055 |
114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22826242 |
115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22677712 |
116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.22457523 |
117 | Base excision repair_Homo sapiens_hsa03410 | 0.21179573 |
118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19142688 |
119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18148879 |
120 | Adherens junction_Homo sapiens_hsa04520 | 0.16905066 |